Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Quizartinib Hydrochloride

Generic Name: Quizartinib Hydrochloride

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 1 Study of Quizartinib

Phase 1

Completed

Posted: 2016/02/05

Sponsor:Daiichi Sankyo Co., ...

ID:NCT02675478

Open Label Study to Evaluate Safety and Efficacy of 2 Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 2

Completed

Posted: 2012/03/29

Sponsor:Daiichi Sankyo

ID:NCT01565668

A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)

Phase 1

Completed

Posted: 2011/11/09

Sponsor:Daiichi Sankyo

ID:NCT01468467

AC220 for Children With Relapsed/Refractory ALL or AML

Phase 1

Completed

Posted: 2011/08/08

Sponsor:

Therapeutic Advances...

ID:NCT01411267

A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)

Phase 1

Completed

Posted: 2011/07/11

Sponsor:Daiichi Sankyo

ID:NCT01390337

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

Invivoscribe's LeukoStrat CDx FLT3 Mutation Assay Receives Regulatory Approval in UK and Switzerland

2 months ago

The LeukoStrat CDx FLT3 Mutation Assay has been officially registered with regulatory agencies in the United Kingdom and Switzerland, expanding access to critical diagnostics for acute myeloid leukemia patients.

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy